Muscarinic receptor antagonists: Effects on pulmonary function

96Citations
Citations of this article
234Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In healthy lungs, muscarinic receptors control smooth muscle tone, mucus secretion, vasodilation, and inflammation. In chronic obstructive pulmonary disease (COPD) and asthma, cholinergic mechanisms contribute to increased bronchoconstriction and mucus secretion that limit airflow. This chapter reviews neuronal and nonneuronal sources of acetylcholine in the lung and the expression and role of M 1, M 2, and M 3 muscarinic receptor subtypes in lung physiology. It also discusses the evidence for and against the role of parasympathetic nerves in asthma, and the current use and therapeutic potential of muscarinic receptor antagonists in COPD and asthma. © 2012 Springer-Verlag Berlin Heidelberg.

Cite

CITATION STYLE

APA

Buels, K. S., & Fryer, A. D. (2012). Muscarinic receptor antagonists: Effects on pulmonary function. Handbook of Experimental Pharmacology. https://doi.org/10.1007/978-3-642-23274-9_14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free